Publication | Open Access
A randomized controlled trial of methotrexate for patients with generalized myasthenia gravis
129
Citations
19
References
2016
Year
This study provides Class I evidence that for patients with generalized MG MTX does not significantly reduce the prednisone AUDTC over 12 months of therapy.
| Year | Citations | |
|---|---|---|
Page 1
Page 1